Clinical Trial Update: CCRC: Effects of Partially Hydrolyzed Whey Peptides (PHWP) On Weight Loss In Individuals With The Metabolic Syndrome (METS) [NA]

View source ↗

Summary

Clinical trial update on weight loss effects of partially hydrolyzed whey peptides in individuals with metabolic syndrome; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Overweight

Drugs mentioned

• Partially Hydrolyzed Whey Peptides (PHWP)

Snippet

Sponsor: Sidika E. Karakas, MD | Conditions: Metabolic Syndrome, Overweight | NA | Status: COMPLETED